In earnings calls, diabetes tech companies had less to say about tariffs and focused more on future growth.

Philips wants to create a foundation model for MRI to address challenges that are specific to the imaging technique.

Roche Diagnostics plans to produce glucose monitors at the site within three years and prepare for future generations of its ...

As a result of the restructuring, Embecta expects pretax savings between $7 million and $8 million during the second half of ...

The commission is taking steps to target roughly $107 billion worth of imports if it can’t make a tariff deal with the U.S.

Dave Rosa, Intuitive Surgical’s president, will take over as chief executive on July 1, as the surgical robot maker accelerates the rollout of its latest da Vinci system.

CEO Bryan Hanson said tariffs have given “a higher sense of urgency” to the company’s existing efforts to regionalize its ...

Vicarious Surgical and SS Innovations marked progress toward bringing their robotic surgery systems to the U.S. market. The ...

By Wednesday, the two countries will charge 10% baseline duties during the period and remove certain retaliatory levies that ...

Whitaker repeated a call for “zero-for-zero” reciprocal tariffs between the U.S. and its trade partners in testimony before a Senate Finance Committee panel on critical supply chains.

New Insulet CEO Ashley McEvoy set out her priorities for the diabetes technology company on Thursday. “Insulet is already a standout success story,” McEvoy told investors during her first call after ...